ask="4.81"
ask_size="500"
average_daily_volume="622162"
bid="4.45"
bid_size="200"
book_value="2.30"
change="+0.12"
change_from_200_day_moving_average="0.16"
change_from_50_day_moving_average="-0.14"
change_from_52_week_high="-2.13"
change_From_52_week_low="1.62"
change_in_percent="+2.61%"
close="4.72"
dividend_pay_date="12/30/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.68"
ebitda="-43.09M"
eps_estimate_current_year="-1.47"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="-0.84"
ex_dividend_date="12/31/2013"
float_shares="40197000"
high="4.79"
high_52_weeks="6.85"
last_trade_date="1/4/2017"
last_trade_price="4.72"
last_trade_size="7886"
last_trade_time="4:00pm"
low="4.59"
low_52_weeks="3.10"
market_capitalization="308.82M"
moving_average_200_day="4.56"
moving_average_50_day="4.86"
name="Aralez Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="9.83"
open="4.59"
pe_ratio="N/A"
peg_ratio="-0.10"
percent_change_from_200_day_moving_average="+3.40%"
percent_change_from_50_day_moving_average="-2.83%"
percent_change_from_52_week_high="-31.09%"
percent_change_from_52_week_low="+52.26%"
previous_close="4.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.00"
price_per_sales="7.48"
revenue="40.23M"
shares_outstanding="65427000"
short_ratio="6.27"
stock_exchange="NMS"
symbol="ARLZ"
volume="639514"
weeks_range_52="3.10 - 6.85"
